Combination therapies involving cefiderocol, tigecycline, or sulbactam generally showed lower odds of death compared with IV colistin alone, although most estimates did not reach statistical significance.
← all excerpts
Comparative effectiveness of antimicrobial regimens for pneumonia caused by drug-resistant Acinetobacter baumannii: a network meta-analysis including cefiderocol and inhaled therapies.
1
—
—